152 related articles for article (PubMed ID: 22630586)
1. Purpuric drug eruption and alopecia induced by erlotinib.
Nakamura-Wakatsuki T; Yamamoto T
Dermatol Online J; 2012 May; 18(5):16. PubMed ID: 22630586
[TBL] [Abstract][Full Text] [Related]
2. Erlotinib-induced scalp perifolliculitis.
Rallis E; Petronic-Rosic V; Korfitis C
Skinmed; 2012; 10(2):70-1. PubMed ID: 22545319
[TBL] [Abstract][Full Text] [Related]
3. A case of bullous dermatitis induced by erlotinib.
Oteri A; Cattaneo MT; Filipazzi V; Ferrario S; Gambaro A; Isabella L; Tosca N; Clementi E; Radice S; Piazza E
Oncologist; 2009 Dec; 14(12):1201-4. PubMed ID: 19965913
[TBL] [Abstract][Full Text] [Related]
4. Rosaceiform eruption induced by erlotinib.
Patrizi A; Bianchi F; Neri I
Dermatol Ther; 2008 Oct; 21 Suppl 2():S43-5. PubMed ID: 18837734
[TBL] [Abstract][Full Text] [Related]
5. [Henoch-schönlein purpura induced by erlotinib (Tarceva): a case report].
Yuba T; Nagata K; Shiotsu S; Okano A; Hatsuse M; Murakami S; Morihara K; Shimazaki C
Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):81-5. PubMed ID: 20163028
[TBL] [Abstract][Full Text] [Related]
6. Erlotinib induced target-like purpura.
Rungtrakulchai R; Rerknimitr P
Dermatol Online J; 2014 Feb; 20(2):. PubMed ID: 24612572
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous side-effects of epidermal growth factor receptor-tyrosine kinase inhibitor (TKI) in the treatment of lung cancer: description and its management.
Ong CK; Tan WC; Chan LC; Abdul Razak M
Med J Malaysia; 2012 Apr; 67(2):222-3. PubMed ID: 22822651
[TBL] [Abstract][Full Text] [Related]
8. Dimorphic cutaneous manifestation of a toxic eruption due to erlotinib therapy.
Campbell TM; Brown CW
J Drugs Dermatol; 2008 Dec; 7(12):1161-3. PubMed ID: 19137770
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor.
Santoro F; Cozzani E; Parodi A
J Dermatolog Treat; 2006; 17(3):160-1. PubMed ID: 16854757
[TBL] [Abstract][Full Text] [Related]
10. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
Eames T; Landthaler M; Karrer S
Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151
[No Abstract] [Full Text] [Related]
11. Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases.
Cho YT; Chen KL; Sheen YS; Yang CW; Liau JY; Cheng YP; Chu CY
JAMA Dermatol; 2017 Sep; 153(9):906-910. PubMed ID: 28538945
[TBL] [Abstract][Full Text] [Related]
12. Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab.
Bragg J; Pomeranz MK
Dermatol Online J; 2007 Jan; 13(1):1. PubMed ID: 17511934
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced prevention of erlotinib-induced skin rash is transient: a new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects.
Gerber PA; Enderlein E; Homey B; Muller A; Boelke E; Budach W
J Clin Oncol; 2007 Oct; 25(29):4697-8; author reply 4698-9. PubMed ID: 17925571
[No Abstract] [Full Text] [Related]
14. Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.
Benomar S; Boutayeb S; Afifi Y; Hamada S; Bouhllab J; Hassam B; Errihanni H
Dermatol Online J; 2009 Nov; 15(11):2. PubMed ID: 19951638
[TBL] [Abstract][Full Text] [Related]
15. Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib.
Hepper DM; Wu P; Anadkat MJ
J Am Acad Dermatol; 2011 May; 64(5):996-8. PubMed ID: 21496710
[No Abstract] [Full Text] [Related]
16. Erlotinib-induced generalized eczema craquelé and follicular rash sparing the previous radiation field.
Chiu HY; Cheng YP; Jee SH; Tsai TF
Clin Exp Dermatol; 2012 Dec; 37(8):922-4. PubMed ID: 22731795
[No Abstract] [Full Text] [Related]
17. Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva).
Lübbe J; Masouyé I; Dietrich PY
Dermatology; 2008; 216(3):247-9. PubMed ID: 18182820
[TBL] [Abstract][Full Text] [Related]
18. Erlotinib for pretreated squamous cell carcinoma of the lung in Japanese patients.
Hata A; Katakami N; Kunimasa K; Yoshioka H; Fujita S; Kaji R; Tachikawa R; Tomii K; Imai Y; Iwasaku M; Ishida T
Jpn J Clin Oncol; 2011 Dec; 41(12):1366-72. PubMed ID: 22058419
[TBL] [Abstract][Full Text] [Related]
19. Erlotinib induced skin rash spares skin in previous radiotherapy field.
Mitra SS; Simcock R
J Clin Oncol; 2006 Jun; 24(16):e28-9. PubMed ID: 16735697
[No Abstract] [Full Text] [Related]
20. Painful annular pustular drug eruption induced by erlotinib in a patient with non-small cell lung cancer.
Lin TC; Wu PY
Cutis; 2011 Dec; 88(6):281-3. PubMed ID: 22372166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
